Purpose: The purpose of this study was to assess ordering of human papillomavirus (HPV) testing for normal cervical cytology among low-risk women aged 30 to 65 years. Methods: Audits of 833 cytology request forms for low-risk women completing a Papanicolaou smear, from January 2008 to April 2011, from 5 Michigan family medicine clinics determined HPV or-ders completed by the clinician performing the Papanicolaou smear. Multivariate logistic regression models examined differences in HPV test ordering by patient age at Papanicolaou test, provider status and sex, and clinic across sites. A Poisson regression model analyzed the annual number of HPV test orders over time. Results: Cytology requests were completed by 622 faculty (75%), 169 reside...
ObjectiveThe primary cervical cancer screening strategy for women over age 30 is high-risk human pap...
Objectives: The objectives of the study were to evaluate the patterns of cervical smear cytology in ...
Background: The objective of this studywas to evaluate the clinical performance of the Cervista HPV ...
Background: Human papillomavirus (HPV) DNA testing is more sensitive than cytology for detection of ...
Purpose: Cervical cancer prevention for older women can be challenging since there are no specific g...
Although cytology‐based screening programs have significantly reduced mortality and morbidity from c...
BACKGROUND. High-risk human papillomavirus (HR-HPV) testing has been proposed as a replacement for c...
Human Papillomavirus (HPV)-based management of women with borderline (ASCUS) or mildly abnormal (CIN...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Objectives: Primary cervical screening uses cytology to detect cancer precursor lesions [cervical in...
The present study was designed to further assess the validity of the cytological description of morp...
Introduction: Human papillomavirus (HPV) is the major cause of cervical cancer, which is the second ...
The official published version of the article can be found at the link below.Objectives: Primary cer...
<p>Consistent evidence underlines the utility of human papillomavirus (HPV) DNA testing in the...
Background: Pap screening, an effective method for cervical cancer prevention, is now supported by m...
ObjectiveThe primary cervical cancer screening strategy for women over age 30 is high-risk human pap...
Objectives: The objectives of the study were to evaluate the patterns of cervical smear cytology in ...
Background: The objective of this studywas to evaluate the clinical performance of the Cervista HPV ...
Background: Human papillomavirus (HPV) DNA testing is more sensitive than cytology for detection of ...
Purpose: Cervical cancer prevention for older women can be challenging since there are no specific g...
Although cytology‐based screening programs have significantly reduced mortality and morbidity from c...
BACKGROUND. High-risk human papillomavirus (HR-HPV) testing has been proposed as a replacement for c...
Human Papillomavirus (HPV)-based management of women with borderline (ASCUS) or mildly abnormal (CIN...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Objectives: Primary cervical screening uses cytology to detect cancer precursor lesions [cervical in...
The present study was designed to further assess the validity of the cytological description of morp...
Introduction: Human papillomavirus (HPV) is the major cause of cervical cancer, which is the second ...
The official published version of the article can be found at the link below.Objectives: Primary cer...
<p>Consistent evidence underlines the utility of human papillomavirus (HPV) DNA testing in the...
Background: Pap screening, an effective method for cervical cancer prevention, is now supported by m...
ObjectiveThe primary cervical cancer screening strategy for women over age 30 is high-risk human pap...
Objectives: The objectives of the study were to evaluate the patterns of cervical smear cytology in ...
Background: The objective of this studywas to evaluate the clinical performance of the Cervista HPV ...